Systemic gold therapy.
Papp
K A
KA
Department of Medicine (Dermatology and Clinical Pharmacology), University of Toronto, Ontario, Canada.
Shear
N H
NH
D000284:Administration, Oral; D001168:Arthritis / Q000188:drug therapy; D001310:Auranofin / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D006051:Aurothioglucose / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D006052:Gold Sodium Thiomalate / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D006801:Humans; D012871:Skin Diseases / Q000188:drug therapy
D006052:Gold Sodium Thiomalate; D006051:Aurothioglucose; D001310:Auranofin